3,4 Both strategies are utilized to augment the incretin effect, but there are key clinical differences among the DPP-4 inhibitors and GLP-1 receptor agonists
According to Medicare.gov, the drugs included from July 1, 2026 are Foundayo tablets, Wegovy injection or tablets, and Zepbound in the KwikPen presentation only, and the prescriber must certify that the medication is being used as part of a lifestyle program focused on diet and exercise
Remember that supplements work best when they are part of a holistic lifestyle
The GLP-1 data presented to date are based on: Large observational cohort studies Retrospective comparative effectiveness analyses Meta-analytic pooling of observational datasets They are not yet based on dedicated randomized clinical trials designed specifically to evaluate colorectal cancer incidence or adenoma prevention as primary endpoints
The information available on our United Kingdom Direct Peptides website: is provided for educational purposes only